In Vitro Strategies to Vascularize 3D Physiologically Relevant Models
Abstract Vascularization of 3D models represents a major challenge of tissue engineering and a key prerequisite for their clinical and industrial application. The use of prevascularized models built from dedicated materials could solve some of the actual limitations, such as suboptimal integration o...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202100798 |
id |
doaj-2ccaecc2df2a44b98b461bb8432b67d5 |
---|---|
record_format |
Article |
spelling |
doaj-2ccaecc2df2a44b98b461bb8432b67d52021-10-08T09:03:05ZengWileyAdvanced Science2198-38442021-10-01819n/an/a10.1002/advs.202100798In Vitro Strategies to Vascularize 3D Physiologically Relevant ModelsAlessandra Dellaquila0Chau Le Bao1Didier Letourneur2Teresa Simon‐Yarza3Université de Paris INSERM U1148 X Bichat Hospital Paris F‐75018 FranceUniversité de Paris INSERM U1148 X Bichat Hospital Paris F‐75018 FranceUniversité de Paris INSERM U1148 X Bichat Hospital Paris F‐75018 FranceUniversité de Paris INSERM U1148 X Bichat Hospital Paris F‐75018 FranceAbstract Vascularization of 3D models represents a major challenge of tissue engineering and a key prerequisite for their clinical and industrial application. The use of prevascularized models built from dedicated materials could solve some of the actual limitations, such as suboptimal integration of the bioconstructs within the host tissue, and would provide more in vivo‐like perfusable tissue and organ‐specific platforms. In the last decade, the fabrication of vascularized physiologically relevant 3D constructs has been attempted by numerous tissue engineering strategies, which are classified here in microfluidic technology, 3D coculture models, namely, spheroids and organoids, and biofabrication. In this review, the recent advancements in prevascularization techniques and the increasing use of natural and synthetic materials to build physiological organ‐specific models are discussed. Current drawbacks of each technology, future perspectives, and translation of vascularized tissue constructs toward clinics, pharmaceutical field, and industry are also presented. By combining complementary strategies, these models are envisioned to be successfully used for regenerative medicine and drug development in a near future.https://doi.org/10.1002/advs.2021007983D cell culturebioprintingmicrofluidicstissue engineeringvascularization |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alessandra Dellaquila Chau Le Bao Didier Letourneur Teresa Simon‐Yarza |
spellingShingle |
Alessandra Dellaquila Chau Le Bao Didier Letourneur Teresa Simon‐Yarza In Vitro Strategies to Vascularize 3D Physiologically Relevant Models Advanced Science 3D cell culture bioprinting microfluidics tissue engineering vascularization |
author_facet |
Alessandra Dellaquila Chau Le Bao Didier Letourneur Teresa Simon‐Yarza |
author_sort |
Alessandra Dellaquila |
title |
In Vitro Strategies to Vascularize 3D Physiologically Relevant Models |
title_short |
In Vitro Strategies to Vascularize 3D Physiologically Relevant Models |
title_full |
In Vitro Strategies to Vascularize 3D Physiologically Relevant Models |
title_fullStr |
In Vitro Strategies to Vascularize 3D Physiologically Relevant Models |
title_full_unstemmed |
In Vitro Strategies to Vascularize 3D Physiologically Relevant Models |
title_sort |
in vitro strategies to vascularize 3d physiologically relevant models |
publisher |
Wiley |
series |
Advanced Science |
issn |
2198-3844 |
publishDate |
2021-10-01 |
description |
Abstract Vascularization of 3D models represents a major challenge of tissue engineering and a key prerequisite for their clinical and industrial application. The use of prevascularized models built from dedicated materials could solve some of the actual limitations, such as suboptimal integration of the bioconstructs within the host tissue, and would provide more in vivo‐like perfusable tissue and organ‐specific platforms. In the last decade, the fabrication of vascularized physiologically relevant 3D constructs has been attempted by numerous tissue engineering strategies, which are classified here in microfluidic technology, 3D coculture models, namely, spheroids and organoids, and biofabrication. In this review, the recent advancements in prevascularization techniques and the increasing use of natural and synthetic materials to build physiological organ‐specific models are discussed. Current drawbacks of each technology, future perspectives, and translation of vascularized tissue constructs toward clinics, pharmaceutical field, and industry are also presented. By combining complementary strategies, these models are envisioned to be successfully used for regenerative medicine and drug development in a near future. |
topic |
3D cell culture bioprinting microfluidics tissue engineering vascularization |
url |
https://doi.org/10.1002/advs.202100798 |
work_keys_str_mv |
AT alessandradellaquila invitrostrategiestovascularize3dphysiologicallyrelevantmodels AT chaulebao invitrostrategiestovascularize3dphysiologicallyrelevantmodels AT didierletourneur invitrostrategiestovascularize3dphysiologicallyrelevantmodels AT teresasimonyarza invitrostrategiestovascularize3dphysiologicallyrelevantmodels |
_version_ |
1716838566945882112 |